← Evidence map

ArticlePloS one2024

Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease.

Joseph Walden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 38917111